Table 2.

Antimicrobial resistance pattern for ESBL and Non- ESBL bacteria isolates, (% of resistance isolates within each group)

Antibiotic	E. coli		K. pneumoniae		E. cloacae		C. freundii		P. mirabilis		M. morganii		P. rettgeri
	ESBL(+) (n = 15)	ESBL (−) (n = 95)	ESBL (+) (n = 9)	ESBL (−) (n = 18)	ESBL (+) (n = 6)	ESBL (−) (n = 5)	ESBL (+) (n = 4)	ESBL (−) (n = 5)	ESBL (+) (n = 5)	ESBL (−) (n = 2)	ESBL (+) (n = 2)	ESBL (−) (n = 5)	ESBL (−) (n = 1)
AMC	NA	14.7	NA	44.4	NA	80	NA	50	NA	0	NA	20	100
CTX	NA	0.0	NA	0	NA	0	NA	0	NA	0	NA	0	0
CTZ	NA	0.0	NA	0	NA	0	NA	0	NA	0	NA	0	0
CRO	NA	1.1	NA	0	NA	0	NA	0	NA	0	NA	0	0
IMP	0	0	0	0	0	0	0	0	0	0	0	0	0
CHL	26.7	37.9	88.9	50	83.3	20	75	0	100	0	100	60	100
CIP	86.7	27.4	66.7	22.2	83.3	0	50	0	100	0	100	60	0
DO	100	73.7	66.7	44.4	83.3	60	100	40	100	100	100	80	100
CN	80	18	88.9	22.2	50	0	75	0	100	0	100	20	0
NAL	86.7	37.9	66.7	27.8	75	20	100	0	100	0	100	80	100
NIT	33.3	10.5	77.8	33.3	83.3	60	75	20	100	100	100	100	100
SXT	93.3	72.6	66.7	72.2	83.3	20	75	20	100	0	100	80	0

AMC Amoxicillin-clavulanic acid, CTX cefotaxime, CTZ ceftazidime, CRO ceftriaxone, IMP imipenem, CHL chloramphenicol, CIP ciprofloxacin, DO doxycycline, CN gentamicin, NAL nalidixic acid, NIT nitrofurantoin, SXT trimethoprim-sulfamethoxazole

NA Not applicable